Intersecting Issues

RSS Feed for this category

Chronicle AM: TN Pregnant Women Drug Law Fails, AR Welfare Drug Testing Starting, More... (3/24/16)

An asset forfeiture reform bill moves in New Hampshire, Arkansas and West Virginia advance welfare drug testing, a global commission on public health calls for drug decriminalization, and more.

Medical Marijuana

Louisiana House Committee Approves Bill to Set Up Medical Marijuana Shops. The House Health and Welfare Committee Wednesday approved House Bill 446, sponsored by Rep. H. Bernard LeBas (D-Ville Platte). The bill would create a licensing scheme for the distribution of medical marijuana products. The bill now heads for a House floor vote. It must still be approved by the Senate.

More Michigan Protests Over Dispensary Raids. Dozens of patients, advocates, and supporters took to the steps of the state capitol in Lansing Tuesday to protest a new wave of raids by the Michigan State Police and local narcotics teams. Both state Sen. Coleman Young (D-Detroit) and Rep. Jeff Irwin (D-Ann Arbor) addressed the crowd.

Heroin and Prescription Opioids

Kentucky Senate Restores Funding for Heroin Fight. The Senate Wednesday agreed to restore $12 million in funding for anti-heroin efforts that had been proposed by Gov. Matt Bevin (R), but cut by the House last week. House Democrats had slashed the $32 million over two years proposed by the governor to $20 million. Now, the House and Senate will have to thrash out the difference in conference committee.

Asset Forfeiture

New Hampshire House Approves Bill to End Civil Asset Forfeiture. The House Wednesday approved House Bill 636, which would require a criminal conviction before assets could be seized and which would move seized goods from the drug forfeiture fund to the state's general fund. Gov. Maggie Hassan (D) is threatening to veto the bill, saying that because of the state's opioid crisis, this isn't the time to eliminate law enforcement resources.

Drug Policy

Hawaii Lawmakers Take Up Resolution Urging Study on Drug Decriminalization. The House Judiciary Committee today is hearing a resolution, HCR 127, that calls on the state's Legislative Research Bureau to "conduct a study on the feasibility and advisability of decriminalizing the illegal possession of drugs for personal use in Hawaii" so that it "would constitute an administrative or civil violation rather than a criminal offense." If the resolution passes both chambers, the study would be due before year's end to be ready for next year's legislative session. The study would examine Portugal's experience with decriminalization as a possible model for the state.

Drug Testing

Arkansas Welfare Drug Testing to Begin Within Days. The head of the Department of Workforce Services, Daryl Bassett, said Wednesday that the state's welfare drug testing program would get underway within "seven to 10 days." Under the program, all applicants for government aid would be screened for possible drug use and those deemed likely to have been using drugs would have to undergo drug testing. Refusal to take the drug test will result in being denied benefits for six months. Someone who tests positive can continue to receive aid if he follows treatment and recovery plans set by state officials.

West Virginia Governor Signs Welfare Drug Test Bill. Gov. Early Ray Tomblin (D) today signed into law a bill that mandates screening of all welfare applicants for drug use and drug testing those for whom case workers have "reasonable suspicion" of drug use. Applicants who fail drug tests can continue to receive benefits as long as they enroll in drug treatment and job training programs, but a second failed test could mean loss of benefits for up to a year, and a third would earn a lifetime ban.

Harm Reduction

King County Sheriff Says He Would Not Arrest Drug Users Going to Seattle Safe Injection Site. King County Sheriff John Urquhart edged ever closer Tuesday to outright support of a safe injection site in Seattle. "I guarantee you," said Urquhart, "that if you're going into a safe injection site, you will not be arrested by any of my deputies, period." But he was careful to add that while he was "intrigued" by the success of Vancouver's InSite supervised injection facility, he is not yet ready to endorse them for Seattle.

Pregnancy

Tennessee Law That Allows Assault Charges for Pregnant Drug Users Not Renewed. The state's two-year experiment with arresting pregnant drug users is about to come to an end after the legislature failed to re-authorize the law this week. At least a hundred women have been prosecuted under the program, which has been condemned by human rights, civil rights, and pregnant women's rights advocates.

International

Leading Global Health Commission Calls for Reform of Drug Policies Worldwide. A leading global public health commission is calling for new policies that would transform our approach to drug use, addiction and control worldwide, including the decriminalization of minor and non-violent drug offenses. According to a report released this morning by the Johns Hopkins Bloomberg School of Public Health and The Lancet, the war on drugs and zero-tolerance policies have undercut public health across the globe and have directly contributed to many of today's most urgent public health crises, while doing little to affect drug markets or drug use. The Johns Hopkins University -- Lancet Commission on Public Health and International Drug Policy calls for worldwide reform of drug policies, including: the decriminalization of minor and non-violent drug use, possession and petty sale; enactment of policies that reduce violence and discrimination in drug policing; increased access to controlled medicines that could reduce the risk of overdose deaths; and greater investments in health and social services for drug users. The report is based on an extensive review by the Commissioners of the published evidence, and on original analyses and modeling on violence, incarceration and infectious diseases associated with drug policies.

Chronicle AM: Joep, We Miss You; Supreme Court Rejects NE, OK Pot Lawsuit; Bud Business Going Big, More... (3/21/16)

The international drug reform movement has lost a valued member way too soon, the Supreme Court rejects Nebraska and Oklahoma's efforts to derail Colorado's pot law, a new report says the pot business is going big, Ohio medical marijuana initiatives keep hitting roadblocks, and more.

A $23 billion industry by 2020? Arcview thinks so. (wikimedia.org/hampuforum)
Marijuana Policy

Supreme Court Rejects Nebraska and Oklahoma Lawsuit Over Colorado Marijuana Legalization. The US Supreme Court today declined to hear the case brought by Nebraska and Oklahoma against Colorado's marijuana legalization law. The two states had claimed the Colorado law created an increased law enforcement burden in their states and claimed that federal marijuana prohibition trumps the state law. But the Obama administration urged the high court to reject the case, and today it did on a 6-2 vote.

Legal Marijuana Could Be a $23 Billion Business By 2020, Report Says. In its 4th Edition State of Legal Marijuana Markets Report, the Arcview Market Research and the data-analysis firm New Frontier said that the legal marijuana industry is creating thousands of jobs and is online to reach $23 billion in sales by 2020, driven largely by adult use.

Vermont House Panels Will Hold Hearing on Pot Legalization Bill on March 31. The House committees on Judiciary and on Government Operations will hold a joint hearing on the marijuana legalization bill, Senate Bill 241. The measure has already passed the Senate, and Gov. Peter Shumlin (D) supports it. If the bill passes, Vermont will become the first state to legalize it via the legislative process.  

Medical Marijuana

Ohio Attorney General Rejects Two More Initiatives. It's back to the drawing board for two more medical marijuana initiatives after Attorney General Mike DeWine found problems with their ballot language. The Medical Cannabis and Industrial Hemp Amendment, submitted by a group led by attorney and veteran marijuana activist Don Wirstshafter, had inconsistencies between its text and its summary, DeWine said. Last Friday, he rejected a fourth petition for the Ohio Medical Cannabis Amendment for similar reasons. The groups behind the initiatives will now have to gather an additional 1,000 signatures and then resubmit their initiatives.

Heroin and Prescription Opioids

New CDC Prescribing Guidelines Urge Doctors Not to Test for Marijuana. New Centers for Disease Control and Prevention (CDC) guidelines aimed at reducing opiate addiction and overdose deaths recommend that doctors stop drug testing patients for the presence of THC and discourages them from dropping patients who test positive for pot. "Clinicians should not test for substances for which results would not affect patient management or for which implications for patient management are unclear. For example, experts noted that there might be uncertainty about the clinical implications of a positive urine drug test for tetrahyrdocannabinol (THC),” the guidelines state. "Clinicians should not dismiss patients from care based on a urine drug test result because this could constitute patient abandonment and could have adverse consequences for patient safety, potentially including the patient obtaining opioids from alternative sources and the clinician missing opportunities to facilitate treatment for substance use disorder."

Asset Forfeiture

Utah Poll Has 86% Opposing Current Asset Forfeiture Laws. A new Public Policy Polling survey commissioned by Drug Policy Action, the lobbying arm of the Drug Policy Alliance, shows overwhelming dissatisfaction with the state's civil asset forfeiture laws. More than three-quarters (77%) of respondents said they were unaware of civil asset forfeiture, but when provided a brief summary, 86% supported the position that "Police should not be able to seize and permanently take away property from people who have not been charged with a crime." The poll comes as asset forfeiture reform legislation has been stalled by organized opposition from law enforcement.

Pregnancy

Tennessee Law That Criminalized Drug Use By Pregnant Women Could Be Modified. On Tuesday, lawmakers will vote to amend the state's "fetal assault" bill, which makes it a crime for women to use drugs while pregnant. The amendment being offered would only prosecute woman who are more than 25 weeks pregnant.  But advocates are calling for a better solution: don't renew the law.

International

European Drug Reform Stalwart Joep Oomen Dead at 54.Joep Oomen, a key figure in European civil society drug reform efforts, has died unexpectedly of natural causes at his home in Antwerp, Belgium. He was found by colleagues dead in bed Friday when they went looking for him after he failed to show up for a meeting.  He was 54 years old. A veteran activist with more than a quarter century of organizing under his belt, Oomen was the co-founder of numerous drug reform NGOs, including the European Coalition for Just and Effective Drug Policies (ENCOD), the Trekt Uw Plant cannabis cultivation social club in Antwerp, and the Dutch Union for the Abolition of Cannabis Prohibtion (VOC). Joep's vision of a world without drug war drew his attention beyond Europe's borders as well. He had been active with groups like Mama Coca and Friends of the Coca Leaf in working to see the coca plant treated with the respect it deserves, and had been a steady presence at organizing around the United Nations' international drug prohibition bureaucracy. We consider Joep a friend and colleague. We are shocked and saddened by his untimely departure.  

Chronicle AM: VT Gov Urges Lawmakers to Pass Legal Pot Bill, House Dems Urge Obama to Stand Tall at UNGASS, More... (3/18/16)

The taxman is happy in Oregon, Vermont's governor would be happy if the House passed the pot bill, New Orleans is a signature away from decriminalizing pot, Wisconsin's governor signs a package of bills to tamp down heroin and pain pill use, and more.

Some House Democrats are calling on President Obama to use the UNGASS on Drugs as a bully pulpit for global drug reform.
Marijuana Policy

Oregon Took in $3.48 Million in Marijuana Taxes in January. Even though legal marijuana is still for sale only through medical marijuana dispensaries, the state still sold an estimated $14 million worth of non-medical weed, resulting in the $3 million-plus funding gift to the state. State officials had predicted the take would be about $1 million.

Vermont Governor Urges House to Pass Legalization Bill. Gov. Peter Shumlin (D) told legislators "the time is now to take a smarter approach to marijuana" in a statement released Friday. "The stakes are important. The bill passed by the Vermont Senate would represent the most careful, deliberate attempt to regulate marijuana in America. Before passing the bill, the Senate took testimony from experts, asked the right questions, and learned lessons from those states that have legalized marijuana already. The result is a bill to create a system which would represent a huge improvement over the status quo….The choice in front of Vermonters and their elected representatives in the next couple of months is whether we want our state to take a rational step to end an antiquated War on Drugs policy that almost everyone agrees has failed. We can take a smarter approach in Vermont and be prepared for whatever other states around us do. But we must have the courage to do it." The House has taken up the legalization bill, Senate Bill 241, this week.  

New Orleans City Council Approves Decriminalization. The council voted unanimously Thursday night to approve an ordinance allowing police to write tickets instead of arresting people caught in possession of small amounts of marijuana. Fines will start at $40 and be capped at $100. The ordinance still needs to be signed by Mayor Mitch Landrieu.

Heroin and Prescription Opioids

Wisconsin Governor Signs Bill Package Targeting Heroin, Pain Pills. The package signed by Gov. Scott Walker (R) includes Assembly Bill 364, which requires doctors to check a database whenever they fill or refill a prescription for abusable drugs; Assembly Bill 365, which requires police to provide information to the Prescription Drug Monitoring database when they find evidence of prescription drugs being abused or stolen; Assembly Bill 366, which requires pain clinics to be certified by the state; Assembly Bill 367, which requires methadone clinics to provide relapse and other information to the state;  Assembly Bill 658, which makes it a crime to possess a use a masking agent to foil a drug test; and Assembly Bill 659, which streamlines rules for opioid treatment programs.

Drug Policy

House Democrats Urge Obama to Go Big at the UNGASS on Drugs. Fourteen House Democrats have urged President Obama to use the UNGASS as a bully pulpit for a call for substantive global drug reforms and moving away from failed criminalization strategies. Led by Reps. Earl Blumenauer (OR) and John Conyers (MI), the group urged the president to "take full advantage of this timely and powerful event to communicate our progress toward a more effective, science-based approach to drugs to the rest of the world." The Democrats called for Obama himself to deliver the US position before the General Assembly. "That unique platform gives you the opportunity to elevate the 2016 UNGASS on the World Drug Problem and change the way drug policy is approached, not only domestically, but also around the world, establishing the United States’ commitment to a new approach on an international scale," the letter reads.

International

Canada Petition Calling for Full Marijuana Legalization Gaining Steam. A petition asking the Canadian government to fully repeal marijuana prohibition is picking up signatures, especially in British Columbia. There are more than 12,000 signatures so far, more than 5,000 of them from BC. The petition launched by federal Green Party leader Elizabeth May calls for removing marijuana from the Controlled Drugs and Substances Act, ending police actions against existing storefronts, granting of pardons and expungements of criminal records to pot criminals, and leaving the regulation and taxation of marijuana commerce to the states. The Liberal government has said it is going to legalize it, but it hasn't said how or when. 

Myths, Moralism, and Hypocrisy Drive the International Drug Control System

Julia Buxton is Associate Dean and Professor of Comparative Politics at the School of Public Policy, Central European University, Budapest. Follow her on Twitter: @BuxtonJulia

This article is published as part of an editorial partnership between openDemocracy and CELS, an Argentine human rights organisation with a broad agenda that includes advocating for drug policies respectful of human rights. The partnership coincides with the United Nations General Assembly Special Session (UNGASS) on drugs.

In April 2016, the international community will convene for the United Nations General Assembly Special Session on the World Drug Problem (UNGASS). This event, held two years early due to the urgency of the drug situation and intensity of drug-related violence, presents an opportunity to question the fundamentals of international drug policy. Despite overwhelming evidence that a century-long quest to control human behavior and drug markets through international treaties and national legislation has failed, there is little expectation of change. The vested interests in retaining the status quo are significant, with sclerosis legitimized through the recurrent exhortation to improve international co-operation.

Major institutional and policy change is required and will ultimately be unavoidable. The treaty system and international drug control institutions stemming from the first international drug conference in 1909 have set us on an orientation within drug policy that does not reflect the dynamics of global drug markets or protect us from drug related harms. Control efforts and resources are skewed toward drugs such as cocaine and heroin, when synthetic drugs such as methamphetamine dominate markets. Enforcement is focused on countries of the global south, when the global north is the world’s key zone for the manufacture and export of illicit substances, and where the bulk of drug trade profits are realized.  

Framed by history

 

From its initiation, the drug control system has responded to the perceived risk from narcotic plants grown in the global south. In 1909, the ‘great powers’ of the day met in Shanghai to discuss controls on opium, a freely traded commodity derived from opium poppy. The result was a seismic market shift, overturning centuries of colonial engagement in opium poppy cultivation in far flung empires of south Asia, and ending the popular use of opium for purposes of pain or pleasure.

The resulting 1912 International Opium Convention of The Hague was the first international drug treaty. It set the intellectual and institutional direction for the drug control system, strategies and approaches that operate today. To put it another way, today we respond to the complex, transnational challenges of HIV/AIDS, internet-based drug sales and international organized crime through a framework devised by imperial powers at a time when women could not vote or wear trousers, when nose size and skin color were seen to determine brain size and civility, and when addiction was understood as a problem of ‘godlessness’.

Over the course of a century, the treaty system has evolved through to the most recent 1988 Convention Against Illicit Traffic in Narcotic Drugs and Psychotropic Substances, incorporating into the control system a diversity of plants, weeds, shrubs and chemicals deemed “evil” and harmful to the “health and welfare of mankind”. At no point has the United Nations, which administers and oversees the treaty system, reconsidered first principles – as set out in 1912 and institutionalized in the 1961 Single Convention on Narcotic Drugs – that it is desirable or even possible for states to prohibit access to a selected range of intoxicating substances. 

Sovereign states remain locked into the goal of eliminating, or at least significantly curbing the production, distribution and use of drugs. They must cooperate on international control efforts and, in line with the 1961 Single Convention, they are required to treat participation in the drug trade as “punishable offenses when committed intentionally”, and as “serious offenses […] liable to adequate punishment particularly by imprisonment or other penalties of deprivation of liberty”.

A legacy of failure

 

These efforts to control human behavior and to terminate the supply of harmful substances cannot succeed, even if recurrently stepped up, militarized and coercively enforced. According to the latest figures from the United Nations Office on Drugs and Crime (UNODC), 1 out of 20 people between the ages of 15 and 64 years used an illicit drug in 2013. This is despite punitive national policies to prevent consumption, including by depriving users of illegal drugs of their freedom, access to their children, employment and medical care, and even their right to life.

The use of cocaine, heroin, cannabis and amphetamines remains a ‘global habit’ in a borderless world, configured around a sophisticated, lucrative and innovative transnational market that supplies a diversity of ever cheaper drugs to an estimated 246 million people.  

The 1961 Single Convention looked to eliminate opium use within 15 years, with a 25-year schedule for cocaine and cannabis. In 1998, the UN promoted a “drug-free world”, to be achieved within ten years, and a host of cultivating countries have, over the decades, committed to achieving zero-cultivation of narcotic drug crops. But just as demand reduction targets have never been met, neither have those relating to supply. At over 7,000 tons in 2014, opium production reached its highest level since the 1930s. There was an estimated 120,000 hectares under coca bush cultivation in 2013 (with potential for the manufacture of 662 to 902 tons of cocaine). Meanwhile, as stated in the UNODC’s “World Drug Report 2015”, advances “in cannabis plant cultivation techniques and the use of genetically selected strains have led to an increase in the number of cannabis harvests, as well as in the yield and potency of cannabis”.

As set out by Yury Fedotov, executive director of the UNODC, “we have to admit that, globally, the demand for drugs has not been substantially reduced and that some challenges exist in the implementation of the drug control system”. This acknowledgement has not led to any questioning of mission, or the plausibility of prohibiting access to certain drugs – even with evidence that nine out of ten users are not considered dependent or problematic. Neither has there been engagement with the reality that making certain substances illegal has made them more attractive to produce and supply. Criminalization has converted freely growing plants into billion dollar crops, high profit margins incentivize illicit supply, while the ‘success’ of drug seizures serves only to elevate prices. A utopian goal is being pursued through a strategy that makes it unachievable. 

A northern bias

 

In policy and implementation, drug control remains overwhelmingly preoccupied with opium poppy and coca leaf. International counter-narcotics efforts and assistance – both military and development – have focused on ‘producer’ states such as Colombia, Bolivia and Peru (coca leaf), Mexico (opium poppy) and south Asian countries such as Afghanistan, Burma and Laos PDR (opium poppy). However, as successive UNODC World Drug Reports demonstrate, opioids and cocaine are not the most widely consumed drugs, or arguably the most dangerous.

Contemporary drug markets, measured in terms of seizures and reported use, are increasingly dominated by synthetic drugs: ‘Amphetamine Type Substances’ (ATS) such as methamphetamine and amphetamine, as well as Ecstasy (MDMA) and a raft of ‘New Psychoactive Substances’ (NPS) of which 450 were reported in 2014. The key manufacture and export zones for these drugs are not the global south, but west and east European countries and north America. Patterns of drug flows are the reverse of the dynamics envisioned in the treaty framework. The old delineation of consumer and producer states no longer exists, and the global north is now the key producer region, including for cannabis.

This raises the more difficult question of accounting for the inconsistent application of counter-narcotics efforts, and the gross inequalities in terms of costs and impacts. An estimated 164,000 people were killed during the counter-narcotics surge of 2007 to 2014 in Mexico, a death toll higher than Iraq and Afghanistan combined. But the thought of militarizing supply control in the Netherlands – a leading producer country – on the level experienced by Mexico, is unconscionable. Why are Colombia, Bolivia and Afghanistan acceptable theaters for violent weaponized counter-narcotic operations, and not Poland or Canada?

Moreover, the lack of high level violence in the drug markets of these northern producer countries signifies that illicit markets can be peaceful. From this perspective, it is the disruptive market interventions, weapons flows and training of paramilitary counter-narcotics units that are the drivers of violence in the global south, not the drug markets themselves. Similarly, in relation to northern interventions, how can it be the case that the EU and US fund cannabis eradication in the global south while legalizing or decriminalizing domestically? 

The north’s deflection of its leading role in the drug trade is institutionalized in the treaty system and international drug control institutions. The result is that we have remarkably little information about the evolving threats to mankind’s ‘health and welfare’ posed by synthetics. As set out in the preface to the 2013 World Drug Report, ATS use “remains widespread globally, and appears to be increasing in most regions”, with crystalline methamphetamine “an imminent threat”. Yet while we have each hectare of coca and opium meticulously researched, there is a paucity of data and information on the manufacture of synthetic drugs, or their consumption. It was not until 2008 that the UNODC launched dedicated ATS analysis through the UNODC Global SMART Program(Synthetics Monitoring: Analyzes, Reporting and Trends), with the aim of generating, analyzing and reporting on the synthetic drug market, and improving global responses to the rise in ATS manufacture, trafficking and consumption.

Drug control is constantly re-legitimized by a moral narrative of protecting health, welfare and security. Yet by downplaying the role of European and North American countries in the drug trade, and the historical salience of synthetic markets by default, the system is creating public health risks, it cannot anticipate change in dynamic markets, and it has an insufficient evidence base for policy. Indicative of this is the acknowledgement in the 2016 World Drug Report that, “the sheer number, diversity and transient nature of NPS currently on the market partly explain why there are still only limited data available on the prevalence of use of many NPS. Those difficulties also explain why both the regulation of NPS and the capacity to address health problems related to NPS continue to be challenging.”

In 2012, the International Narcotic Control Board that monitors treaty enforcement, set out that, “dividing countries into the categories of “drug-producing”, “drug-consuming” or “transit countries” has long ceased to be realistic. To varying degrees, all countries are drug-producers and drug-consumers and have drugs transiting through them.” Despite institutional acknowledgement of market transformations, the new geopolitical realities of the drug trade are not reflected in enforcement activities, in the language of drug control institutions, or in the allocation of resources for research, education, treatment and rehabilitation. These remain concentrated on coca and opium poppy, cocaine and heroin.

From the local to the global level, we are, with some small exceptions, locked into arcane, counterproductive and illogical policies that violate fundamental rights and freedoms, spread disease, exacerbate violence, and which impede development – in the view of other UN agencies. The UNODC, which sits in an institutional silo, uses the benign term “unintended consequences” to refer to the wholly negative impact of counter-narcotics policies and how these are disproportionately borne along stratified racial, class and geographic lines. The myths, Victorian moralism and hypocrisy that frame international drug policy need to be confronted if we are to progress to rights-based interventions that genuinely reduce harm. In other words, drug policies which are fit for the twenty-first century.           

This article is published as part of an editorial partnership between openDemocracy and CELS, an Argentine human rights organization with a broad agenda that includes advocating for drug policies respectful of human rights. The partnership coincides with the United Nations General Assembly Special Session (UNGASS) on drugs.

Chronicle AM: Canada Wakes Up the CND, Tampa Pot Decrim, CA Legalization Init Getting Signatures, More... (3/17/16)

California's leading legalization initiative is one-quarter of the way home, Tampa is the latest Florida locality to decriminalize pot possession, the Canadians wake up the Commission on Narcotic Drugs with a very reform-oriented speech, and more.

Canada came out strong for harm reduction and marijuana legalization at the Commission on Narcotic Drugs in Vienna this week.
Marijuana Policy

California AUMA Legalization Initiative Has 25% of Needed Signatures. The Adult Use of Marijuana Act (AUMA) initiative has accumulated nearly 100,000 signatures since petitioning began in January. It has until July 5 to turn in a total of 365,880 valid voter signatures to qualify for the November ballot. While other initiatives are out there, this one, supported by tech billionaire Sean Parker and Lt. Gov. Gavin Newsom (D), is the one most likely to have the dollars behind to actually make the ballot.

Tampa Decriminalizes Pot Possession. The city council has passed an ordinance that decriminalizes the possession of up to 20 grams of marijuana. The move was supported by the mayor and the police chief. Now, possession will no longer be a misdemeanor, but will be a civil infraction punishable by a $75 fine for a first offense, $150 for a second, and $450 for any subsequent offenses.  Tampa now joins a number of South Florida localities that have decriminalized, as well as Central Florida's Volusia County.

Medical Marijuana

New York State Senator Unveils Medical Marijuana Expansion Package. State Sen. Diane Savino  (D-Staten Island) has introduced a package of bills—Senate Bills 6998, 6999, and 7000—designed to expand the state's constricted medical marijuana program. One bill would allow nurse practitioners to recommend medical marijuana, another would allow the five organizations licensed to grow and sell medical marijuana to double the amount of dispensaries they can open from four to eight, while another would expand the conditions for which marijuana could be recommended.

Law Enforcement

Denver Cops Instructed to Not Punch Suspects Believed to Be Swallowing Drugs. The Denver Police Department's Office of the Independent Monitor recommended Tuesday that the department adopt new policies to provide guidance to officers when they arrest a suspect believed to be trying to swallow the evidence.  "The OIM recommends that the DPD revise its Use of Force Policy to provide specific guidance on what types of force are permitted, and prohibited, to remove potential contraband from the mouths of persons being placed under arrest. The OIM further recommends that this revised policy prohibit the use of strikes to force persons being place under arrest to spit out potential contraband," the report reads. The recommendation comes in the wake of a widely-decried 2014 incident in which an officer was recorded repeatedly punching a man who was allegedly trying to stuff a heroin-filled sweat sock into his mouth.

Sentencing

Groups File Brief Seeking Reduction in Life Sentence for Silk Road's Ross Ulbricht. The Drug Policy Alliance (DPA) filed an amicus brief Thursday urging the US 2nd Court of Appeal to reduced the life without parole sentence meted out to Ross Ulbricht, who was convicted of operating the Silk Road drug sales website. Joining DPA in the brief were Law Enforcement Against Prohibition, JustLeadershipUSA, and retired federal judge Nancy Gertner.  "Mr. Ulbricht’s draconian sentence flies in the face of evolving standards of decency," said Jolene Forman, Staff Attorney at the Office of Legal Affairs for the Drug Policy Alliance and lead author of the brief. "Nationally, lawmakers are working across the political aisle to reduce harsh sentences for drug offenses. And, many of our allies in Europe consider life without parole sentences inhumane."

International

Canada's New Liberal Government Wakes Up the Commission on Narcotic Drugs Meeting. A speech from a Canadian representative at the Commission on Narcotics Drugs (CND) meeting in Vienna this week was met with eruptions of applause from the audience after the speaker, Assistant Deputy Minister of Health Hilary Geller, made clear that the Liberals were embracing harm reduction, including safe injection sites, and marijuana legalization. Geller's speech not only contrasted sharply with the previous Conservative government's anti-drug reform positions, but also with the cautious pronouncements made by other nations. At the end of the speech, the audience of government officials and NGO leaders gave Geller a standing ovation.

Mexico Captures Cartel Leader Tied to Border Shootouts. After a bloody weekend in Reynosa, where at least a dozen people were killed in clashes between cartel gunmen and soldiers and cartel gunmen set up burning street barricades, federal police Monday captured the Gulf Cartel leader who was allegedly the target of the federal action on the border. The man arrested is Cleofas Alberto Martinez Gutierrez, who officials said was the cartel's number two boss in Reynosa. They found him at a Mexico City race track. 

Chronicle AM: CDC Urges Docs to Severely Limit Pain Pill Prescribing, NY Rep Wants Safe Injection Sites, More... (3/16/16

Another poll has a national majority for pot legalization, the Vermont legalization bill is now before the House, the CDC urges doctors to really cut back on pain pill prescriptions, a New York assemblywoman wants supervised injection sites, a Mexican governor wants a pilot program of opium cultivation, and more. 

Prepare for physicians to begin tightening up on writing pain pill 'scrips. (Creative Commons)
Marijuana Policy

Another Poll Has a Narrow National Majority for Legalization. A new national tracking poll conducted by Morning Consult has support for legalization at 52%, with 43% opposed and 5% undecided. That's in line with other major national polls in recent years that generally show support for legalization in the 50s. The most recent Gallup poll had it at 60%.

Massachusetts Sheriffs Oppose Legalization Initiative. More of the usual suspects weigh in against legalization, with the state's sheriffs saying it would destigmatize drug use and make it easier for teens to get their hands on the weed. Last week, the state Hospital Association and leading elected officials, including Gov. Charlie Baker (R), Attorney General Maura Healey (D), and Boston Mayor Marty Walsh (D) came out against the initiative from the Campaign to Regulate Marijuana Like Alcohol in Massachusetts.  

Vermont Legalization Bill Now Before House. Senate Bill 241, the pot legalization bill, is now before the House Judiciary Committee. On Tuesday, Sen. Dick Sears (D-Bennington) and Sen. Joe Benning (R-Caledonia) introduced the bill to the committee.

Medical Marijuana

Georgia CBD Cannabis Oil Bill Revived. Supporters of House Bill 722, which would expand access to CBD cannabis oil, have resurrected the measure by attaching its language to an old Senate bill. It could go to a House vote as early as today. The bill would expand conditions that qualify for CBD cannabis oil and allow companies outside the state to ship it in. Language that would have allowed in-state marijuana cultivation to produce the oil was stripped out earlier in the House.

More Michigan Medical Marijuana Dispensary Raids. The West Michigan Enforcement Team (WEMET) has raided four dispensaries for allegedly selling medical marijuana to cardholders who were not their registered patients. Two were in Saugatuck, one in Allegan City, and one in Pullman. Twelve other Northern Michigan dispensaries were raided last week.

Ohio Medical Marijuana Campaign Resubmits Initiative. That didn't take long. Last Friday, Attorney General Mike DeWine (R) rejected the Ohioans for Medical Marijuana initiative because of deficiencies in its summary. On Tuesday, the campaign submitted revised language. After 20 days of review by state officials, the campaign will then have until July to gather 306,000 valid voter signatures to qualify for the November ballot.

Criminal Justice

Massachusetts Conference Committee Agrees on Ending Driver's License Suspensions for Drug Offenders. House and Senate negotiators announced Tuesday that they had reached agreement on a bill to end the state's long-running policy of automatically suspending for five years the driver's licenses of people convicted of drug crimes. The relic of the 1980s drug war will be officially repealed after the full House and Senate vote on the amended bill. Both houses passed bills, and the conference committee has been ironing out the differences. More than 30 other states have taken similar steps.

Heroin and Prescription Opioids

CDC Urges Docs to Reduce Prescribing Pain Relievers. In a move bitterly decried by chronic pain advocates, the Centers for Disease Control and Prevention (CDC) said Tuesday doctors should only prescribe opioid pain relievers as a last resort. Instead, doctors should urge their patients to try physical therapy, exercise, and over-the-counter medications before using opioids to treat chronic pain. The CDC is recommending not using opioids except to treat cancer and for palliative end-of-life care, using the lowest effective dose of opioids, and limiting prescriptions to three days for short-term pain.

Harm Reduction

New York Assemblywoman Wants Supervised Injection Facilities Statewide. Assemblywoman Linda Rosenthal (D-Manhattan) said Tuesday she will soon introduce a bill to establish the harm reduction facilities. Rosenthal's move comes after Ithaca Mayor Svante Myrick hoisted a proposal for such a facility there. "New York, and nearly every other state across the country, is grappling with a heroin and opioid addiction crisis that has grown to epidemic proportions," said Rosenthal, who heads the Assembly's Committee on Alcoholism and Drug Abuse, in a statement. "Addiction is a public health crisis, and we must address it as such, with aggressive, community-based solutions that reduce harm and provide access to life-saving treatment services."

International

Mexican Governor Proposes Legalizing Opium Cultivation.  Hector Astudillo, governor of violence-plagued Guerrero, said Monday that legalizing opium cultivation for medical purposes might help reduce the violence in his state and the idea should be considered. "Let's do some sort of pilot scheme," Astudillo, a member of President Enrique Pena Nieto's Institutional Revolutionary Party, said. "Provided it's used for medical issues ... It's a way out that could get us away from the violence there has been in Guerrero," he added.

Will UNGASS 2016 Be the Beginning of the End for the War on Drugs?

This article is by Ann Fordham and Martin Jelsma, and is republished from openDemocracy. It is part a series of articles about this April's UNGASS. Further information appears below.

In April 2016, the UN will dedicate, for the third time in its history, a United Nations General Assembly Special Session (UNGASS) to discuss global drug policy. The UNGASS has the potential to be a ground-breaking moment that could change the course of the international drug control system. However, political divisions and entrenched institutional dynamics have dampened hopes that it will go down in history as the beginning of the end of the war on drugs.

At the joint request of Mexico, Colombia and Guatemala, the General Assembly decided to bring forward the convention of a special session to assess "the achievements and challenges in countering the world drug problem", originally foreseen for 2019 or 2020. The three countries stated at the time that "revising the approach on drugs maintained so far by the international community can no longer be postponed", and the UN needed to exercise leadership to "conduct an in-depth review analyzing all available options, including regulatory or market measures, in order to establish a new paradigm that would impede the flow of resources to organized crime groups". An international meeting had to be convened, "capable of taking the decisions necessary to increase the effectiveness of the strategies and instruments with which the global community addresses the challenges of drugs and their consequences".

Conventional drug control wisdom has put forward the view that stopping the supply of drugs at the source would solve the 'world drug problem', but Latin American countries bear witness to the failure of this approach. Stirred into action by the futility of spending billions of dollars to fight an unwinnable and increasingly violent war on drugs, it is no surprise that political leaders from Latin America have been at the forefront of the drug policy debate. From their perspective, the high human cost in terms of violence, insecurity, mass incarceration and the exacerbation of the social and economic vulnerability of some of society’s most marginalised groups – can no longer be justified as necessary collateral damage in pursuit of eradicating drug markets.

A growing group of Latin American and Caribbean countries are calling for a real discussion on alternative policies. In the meantime, Uruguay has moved to create the world's first national legally regulated cannabis market for recreational use, and similar initiatives have happened in the US at the state level. This opening up of the long entrenched and seemingly immovable discussion on prohibitionist drug control principles is unprecedented and has implications for global policy.

In this context, the UNGASS in April represents a critical juncture, an opportunity for an honest evaluation of global drug policy and how to address the most pressing challenges going forward. Secretary General Ban Ki-moon, in recognition of this rare and important opportunity, has urged member states to use the 2016 UNGASS "to conduct a wide-ranging and open debate that considers all options."

The UNGASS preparations

The initial discussions to prepare for the UNGASS were fraught with disagreements over many procedural aspects. These included difficult negotiations over the extent to which the UN Commission on Narcotic Drugs (CND) in Vienna would lead the process; how to strike the right balance between the UN capitals of Vienna, Geneva and New York in the preparations; how to ensure meaningful involvement of all relevant UN agencies, academia and civil society; and – last but not least – how open the debate should be: should it be restricted to a discussion of how to improve the implementation of the 2009 Political Declaration and the achievement of its targets for 2019, or should the UNGASS be an opportunity to challenge the current global drug control strategy, possibly even questioning its foundation of the three UN drug conventions?

 

These difficult negotiations, which on the surface often appeared to be arguments over procedure, reflected the deep political divisions within the international drug policy debate. The much-revered 'Vienna Consensus' continues to weaken as the divide between some governments becomes increasingly irreconcilable. A growing number of countries now believe that the traditional repressive drug control approach, based on zero-tolerance, has not worked and has led to disastrous consequences for human rights, public health, citizen security and sustainable development, and as a result it has to be modernised.

 

Some countries calling for an open and inclusive debate at the UNGASS questioned whether this could be truly achieved with a process led by the Vienna-based drug control apparatus, given that the CND, the UN Office on Drugs and Crime (UNODC) and the International Narcotics Control Board (INCB) have all gained quite a conservative reputation over the decades. Conducting all the preparations in Vienna led to a further problem for inclusivity, given that at least 70 member states do not have permanent representation there and would therefore struggle to fully participate in the process. The point of convening an UNGASS, is that by definition all UN member states and the whole UN system should be included on a equal basis, but limiting the political negotiations on the outcomes exclusively to Vienna, means that in practice the countries and UN agencies not represented in Vienna have much less influence on the process.

In the end, the hard fought-over resolution on the procedures decided that the UNGASS "will have an inclusive preparatory process that includes extensive substantive consultations, allowing organs, entities and specialized agencies of the United Nations system, relevant international and regional organizations, civil society and other relevant stakeholders to fully contribute to the process", while the CND "as the central policymaking body within the United Nations system dealing with drug-related matters, shall lead this process", inviting the president of the General Assembly to "support, guide and stay involved in the process".

UN special sessions are rare and crucial moments in UN-level policy making and are designed to ensure a coherent UN system-wide response to global problems of major concern to the international community. This has so far been less than optimal in discussions on global drug policy. After initial slow engagement from other key UN agencies, significant contributions have now been made from UNDP, UNAIDS and the WHO. The Office of the High Commissioner for Human Rights has also submitted a comprehensive reportthat outlines the most pertinent human rights violations in relation to drug control policies, while the Human Rights Council held a high level panel in September 2015 on the topic of "the impact of the world drug problem on the enjoyment of human rights".

A Civil Society Task Force (CSTF) was convened to ensure the participation of civil society in the process. The CSTF has representatives from every region of the world, as well as representatives of the key affected populations such as people who use drugs and subsistence farmers growing drug-linked crops among others. Initially, formal recognition of the CSTF was challenging – civil society has always had to fight for visibility and access at the CND but over the last year there has been increasing support for this initiative from governments.  A major victory for the CSTF was explicit support from the president of the General Assembly, who presided over an Informal Interactive Stakeholder Dialogue in New York on the 10 February 2016 organised with the CSTF in support of the preparatory process. The calls for progressive policiesbased in principles of harm reduction, of public health and of human rights from global civil society were deafening at the event.

Shifting regional priorities

 

In terms of regional perspectives, as noted above, the impetus for pushing for another UNGASS on drugs followed growing calls for reform from across Latin America at the highest political level. In fact, the previous UNGASS meetings in 1990 and 1998 had been convened in response to similar calls from Colombia and Mexico. Around them, a group of like-minded countries is gradually shaping up around certain positions, including Ecuador, Uruguay and Costa Rica and supported by Brazil and Bolivia on some issues. Caribbean countries have long been largely absent from the debate, not least because discussions have been limited to the CND in Vienna, where few Caribbean countries are represented – although Jamaica has recently joined the chorus of dissent and the discussion on several other islands has intensified.

In terms of European, particularly European Union (EU), engagement, this has been markedly different from Latin America and reflects the fact that Europe has managed to avoid the sharpest edges of a repressive approach to drug control. European countries have not experienced to the same extent, the high human cost in terms of violence, insecurity, and mass incarceration experienced in Latin America.  Of course the context is different, but in addition, many European governments have been pragmatic, have prioritised health care, harm reduction and human rights protection. While in Europe there are some serious issues regarding the criminalisation of people who use drugs and disproportionate sentences for minor drug offences, most European countries have managed to keep a certain distance from the escalation of the war on drugs in the 1980s and 1990s in the US, Latin America and Asia. At the international level, the leadership that EU governments have shown in this regard has been critical in shifting the drug policy narrative towards public health, harm reduction and human rights principles.

On issues where common positions can be found, the EU can have a strong impact on the global debate. For example, a united EU promoted the principle of proper sequencing with respect to ensuring that subsistence farmers have sufficient access to alternative livelihoods before being forced to abandon their drug-linked crops. The EU has also demonstrated unity and commitment on harm reduction and the removal of death penalty for drug offences, although a global consensus on these issues is not yet in sight.

Unfortunately, there are also crucial areas where a strong European voice has been absent, and the EU has failed to understand or acknowledge the sense of urgency and relevance of this UNGASS. This is clearly the case with regard to the shift in priority that Latin American countries are seeking, to move away from arresting small-time dealers and chasing drug shipments towards reducing drug-related violence, organised crime and corruption instead. In a sense, this is a plea for a harm reduction policy on the supply side: the drugs market will not be “eliminated or significantly reduced” by 2019, and it is time to forget the hollow illusion of a drug-free world.

Instead, government policy could be more sophisticated and focus on mitigating the most harmful aspects of the drug trade through reducing the levels of illicit drug market-related violence, crime, insecurity and corruption. This thinking mirrors similar priority shifts that have previously taken place in Europe under the harm reduction banner, with governments taking a pragmatic approach to reduce the harms associated with drug consumption without necessarily seeking to stop the use of drugs. These harm reduction policies and programmes have significantly reduced drug-related harm such as overdose deaths, and HIV and hepatitis C prevalence among people who inject drugs.

Cannabis policy and UN treaties

 

Another example is the lack of EU engagement in the debate about global cannabis policy developments, the result of the absence of a common EU position on cannabis and huge national policy variations. Demonstrating an ostrich-like denial regarding cannabis policy developments in the Americas but also at local levels within the EU, the EU common position for the UNGASS underscores the need to “maintain a strong and unequivocal commitment to the UN conventions” and that there is “sufficient scope and flexibility within the provisions of the UN Conventions to accommodate a wide range of approaches to drug policy”. In addition, the issue of drug control is a low political priority as the EU currently has it hands full with the refugee crisis and existential threats around the euro and the future of European integration.

A game-changing difference between this UNGASS and the preceding ones is the fact that the position of the US has fundamentally changed. No longer among the hardliners, the US has acknowledged, both at the UN but also more recently domestically, that the over-reliance on incarceration has failed. In August 2013, US Attorney General Eric Holder admitted that mandatory minimum sentences for drug offences were ‘draconian’ and that too many Americans had been imprisoned for too long for no good law enforcement justification. He made it clear that the status quo was unsustainable and damaging. In 2015, President Obama began a process to commute the sentences of around 6,000 federal drug offenders. In early 2016 the congressional task force created to examine overcrowding in the federal prison system, recommended the repeal of federal mandatory minimum sentences for drug offences. Different legislative initiatives have been tabled, including the Smarter Sentencing Act, which would cut many mandatory minimums for drug offences in half.

The domino effect of cannabis regulation at state level makes the US less sure-footed of condemning other countries for not stringently adhering to a zero-tolerance approach. Cannabis regulation for recreational use is outside of the scope of the current UN treaty framework for drugs, creating a significant problem for the US since it undermines its credibility to continue defending the conventions as they stand. The big question is whether this will lead to the US accepting more flexibility in policy areas that have been explored elsewhere. These include initiatives such as decriminalisation, drug consumption rooms or the regulation of coca in Bolivia, all policy options that the US currently opposes.

UNGASS outcomes: change of course

 

The past several years have seen significant changes in the global drug policy landscape representing a trend towards more humane and proportional responses based on health, human rights and development principles. To some extent, the UNGASS will acknowledge those advances and thereby consolidate the significant change of course that is happening in various regions of the world. Perhaps the most significant advance will be on the issue of access to controlled medicines – an area that has long been de-prioritised in favour of a focus on repressive, law enforcement-led approaches to reduce the illicit drug trade. Most drugs included in the schedules of the UN conventions also have important medical purposes, and several appear on the WHO “List of Essential Medicines”.  However, the availability of opiate painkillers like morphine for example, has been dramatically low in most developing countries due to overly strict regulations reflecting over-riding concerns about diversion and addiction rather than a need to ensure access to pain relief.

Unfortunately, other areas of progress remain stilted. Russia, alongside several Asian and Middle Eastern countries, has played hardball in the negotiations, effectively putting the brakes on the shifting discourse. The negotiations are driven by consensus, making it unlikely that contested policies in the field of harm reduction, or reforms like decriminalisation, despite being widely accepted and propounded by all relevant UN agencies, will be explicitly recommended in the UNGASS outcome document. Likewise, a clear condemnation of the death penalty for drug offences is probably going to be blocked by a small group of countries. The prophecy that allowing the CND to take full control over the UNGASS preparations would undermine progress towards a more system-wide coherent UN drugs policy seems to be being borne out. Negotiations about the UNGASS outcomes have taken place mostly in ‘informal’ sessions in Vienna, dominated by a minority of member states and from which civil society is excluded from participating or even observing.

For the General Assembly, an obvious priority for this UNGASS would be how to align UN drug policy with the recently adopted new global framework of the Sustainable Development Goals (SDGs), but negotiations in Vienna carry on as if they are negotiating another CND resolution. Submissions from other member states, UN agencies and civil society calling for a recognition of the failure of repressive responses and highlighting the need to connect the drugs issue with the agreed UN priorities for the future of the planet have so far not been reflected in successive drafts of the UNGASS outcome document.  The general tone of these drafts is very much ‘business-as-usual’.

At present, few countries are willing to openly acknowledge the existence of structural deficiencies with regard to UN system-wide coherence, the institutional architecture and the legal treaty framework. No easy solutions are available for reforming the foundations of the global control system and consensus will be hard to find, but a continued denial of the reality of the on-going policy trends and the resulting tensions with the treaty system will not make them disappear. In fact, to do so will hinder the much-needed evolution of the UN drug control system and its ability to adapt to the realities of today. Towards this end, it could be helpful if the UNGASS outcome leads to the convening of an advisory group or an expert panel to think through different scenarios for the future evolution of the system, especially in the lead up to the next important moment in 2019 when member states will have to agree a new global action plan on drugs, hopefully more in line with the broader set of UN priority goals for the next decade.

Although it is clear that the so-called ‘Vienna consensus’ has been breaking apart for some time and there is a growing desire to find viable policy alternatives to repression and punishment, there are still powerful countries and entrenched bureaucracies that are staunchly opposed to any kind of reform. The divisions between member states but also between UN agencies on this issue have become too visible to ignore and the UNGASS is a perfect opportunity for an honest assessment of the performance of the international drug control system and the options for a change of course.

Given the high human cost of the damaging approaches pursued to date, many people around the world have high hopes that governments will not squander this opportunity. And yet, to what extent the UNGASS can really live up to these hopes remains to be seen. The latest dynamics in Vienna do not bode well, as bureaucratic machinations, political complacency and exclusion seem to rule the process. The lack of vision, inclusivity and commitment to finding new solutions to many of the challenges that remain must be strongly condemned, especially given the urgency expressed by those countries that called for this moment in the first place.

This article was written by Ann Fordham of the International Drug Policy Consortium and Martin Jelsma of the Transnational Institute. It is published as part of an editorial partnership between openDemocracy and CELS, an Argentine human rights organisation with a broad agenda that includes advocating for drug policies respectful of human rights. The partnership coincides with the United Nations General Assembly Special Session (UNGASS) on drugs.

Open Letter in Advance of the UNGASS Calls for Obama to Go Bold

With the United Nations General Assembly Special Session (UNGASS) on Drugs at UN headquarters in New York City just a little more than a month away, more than 230 civil rights, health, faith-based, and other organizations sent a letter to President Obama Thursday urging him to use the UNGASS on Drugs to make an international push for a fundamental shift in drug policy away from criminalization and toward public health and human rights approaches.

UN headquarters, New York City (Creative Commons)
The signatories form a broad range of groups, including the American Civil Liberties Union, AIDS United, LatinoJustice PRLDEF, the Fellowship of Reconciliation, the World Hepatitis C Council, as well as dozens of drug reform and harm reduction nonprofits.

The signatories also include NGOs from around the world, from Accion Semilla Bolivia to the Zimbabwe Civil Liberties and Drug Network. As with the domestic sign-ons, the international groups include dozens of drug reform and harm reduction organizations.

All the signatories are united in calling for the US and President Obama to take "a stronger US stance" in areas like human rights, public health, and development and urging the US to promote the initial steps the UN can take in reforming the international drug conventions that form the legal backbone of the global prohibition regime.

The letter urges the administration to call on the UN to appoint an "Expert Advisory Group," whose mandate would be to study tensions faced by the international drug control regime today, and to recommend options for moving forward. Groups argue that the current US stance toward marijuana legalization and international treaties, which relies in part on continued federal prohibition, is "likely to face shrinking credibility internationally as legalization spreads to more states."

"US agencies have played an important role promoting positive reforms like alternatives to incarceration and people-centered public health drug policies," said David Borden, executive director of StoptheDrugWar.org, who coordinated the sign-on letter. "Unfortunately, the current US UNGASS stance avoids engaging with a number of contested human rights issues, such as the death penalty for nonviolent drug offenses, and punts on the obvious treaty questions that legalization raises. We think this is unfortunate at a time when real strides are being made in reforming our domestic policies, partly because of President Obama's vision for criminal justice reform. We think the administration has viable options available to take further productive steps on global drug policy too."

The letter calls on the Obama administration to:

  • Acknowledge the ramifications of recent drug reforms, such as marijuana legalization in Uruguay and some US states.
  • Stand up for human rights by calling for an end to the death penalty for drug offenses, reducing racial disparities in drug law enforcement, and respecting indigenous traditions.
  • Craft a people-centered approach to drug policy by explicitly adopting harm reduction practices, such as syringe exchanges, and rejecting the criminalization of peasant farmers and the eradication of their drug crops in favor of sustainable development.
  • Take a stronger stance on criminal justice reforms by moving toward drug decriminalization, urging sentencing reforms around the globe, and treating pregnant women who use drugs as patients, not criminals.
  • Work toward a more open dialog by having key documents finalized at the UNGASS rather than at closed sessions of the Commission on Narcotic Drugs in Vienna and taking a more inclusive posture toward NGOS and civil society.

We will see next month how much Obama is listening.

Chronicle AM: ME Legalizers Sure Over Invalidated Signatures, Civil Society Groups Sign UNGASS Letter, More... (3/10/16)

A South Dakota GOP lawmaker tells the parents of sick kids they should move to another state if they want to use CBD cannabis oil, Maine legalizers are suing over disqualified signatures, the Senate passes a major bill dealing with heroin and opiates, but without funding, and more. 

UNGASS on Drugs is now just five weeks away. (Creative Commons)
Marijuana Policy

Maine Legalization Initiative Files Lawsuit Over Disqualified Signatures. The Campaign to Regulate Marijuana Like Alcohol today filed a lawsuit in Kennebec County Superior Court challenging a decision by the secretary of state to disqualify more than 17,000 voter signatures because of an issue surrounding one notary's signature. That was enough to knock the measure off the fall ballot, but the campaign says the signatures should be counted because the notary's signature does indeed match the one on file and because the secretary of state acted outside his authority in rejecting the petitions. The court has 30 days to rule.

North Dakota Legalization Initiative Approved for Signature Gathering. Secretary of State Al Jaeger Wednesday approved a marijuana legalization initiative for circulation. Organizers now have until July 11 to gather at least 13,452 valid voter signatures. They say they are aiming at 20,000 to have a cushion.

Medical Marijuana

South Dakota House Kills CBD Cannabis Oil Bill. A bill that would have allowed for the use of CBD cannabis oil was killed in the House Wednesday on a 25-43 vote, with one "no" voter suggesting parents who lobbied for it should move to another state. The measure, Senate Bill 171, had already passed the Senate, and Republican Gov. Dennis Daugard had suggested he would sign it. Rep. Kristin Conzet (R-Rapid City) told people suffering seizure disorders they should move elsewhere. "I don’t like the road that we’re going down at this time," she said. "This is not a bill for South Dakota."

Heroin and Opiates

Senate Overwhelmingly Passes Landmark Opioid Bill – the Comprehensive Addiction and Recovery Act (CARA). The measure now goes on to the House. CARA advances a large number of treatment and prevention measures intended to reduce prescription opioid and heroin misuse, including evidence-based interventions for the treatment of opioid and heroin addiction and prevention of overdose deaths.

White House Will Announce Funding to Fight Drug Addiction. Just hours after the Senate passed the Comprehensive Addiction and Recovery Act (CARA), the Obama administration said it will announce "a significant federal investment" to help fund its goals. Democrats had tried unsuccessfully to add $600 million in funding to the bill, but were blocked by Republicans.

Asset Forfeiture

Florida Poll Finds Strong Support for Ending Civil Asset Forfeiture. A new poll released by Drug Policy Action finds that 84% of registered Florida voters do not think police should be able to seize property from people who have not been convicted of a crime. And two-thirds of those polled said they would be more likely to support a presidential candidate who opposed civil asset forfeiture.  The poll comes as an asset forfeiture reform bill, Senate Bill 1044, passed out of the legislature Wednesday and awaits the signature of Gov. Rick Scott (R).

Drug Testing

West Virginia House Overwhelmingly Approves Welfare Drug Testing Bill. The bill, Senate Bill 6, would mandate drug testing for any welfare applicant who gives state workers "reasonable suspicion" he or she is using drugs, including having a drug conviction in the previous three years. The bill has already been approved by the Senate, but that body will have to take it up again in concurrence since the House added amendments note voted on in the Senate.

International

Civil Rights, Health, Faith-Based, Justice Reform Groups Call on Obama to Push to End Global Drug War. More than 225 civil rights, health, faith-based and other organizations sent a letterto President Obama Thursday calling on him to use an upcoming United Nations high-level session on global drug policies to push for a fundamental change in course away from criminalization. The letter was submitted as the UN prepares for its highest level session on drug policy since 1998 – the "UN General Assembly Special Session on the World Drug Problem,"or UNGASS, scheduled for April 19-21 at UN headquarters in New York. US diplomats and drug and crime officials have played a central role in negotiations over the UNGASS Outcome Document, an official product of the meeting that will impact policy.The sign-on campaign for the letter was coordinated by David Borden, executive director of StoptheDrugWar.org.

Chronicle AM: UK Lib Dems Call for Marijuana Legalization, MD Harm Reduction Bills Get Hearing, More... (3/8/16)

Massachusetts lawmakers have problems with pot legalization, a Utah medical marijuana bill gets gutted, a Florida medical marijuana bill goes to the governor, groundbreaking harm reduction bills get a hearing in Maryland, Britain's Liberal Democrats call for pot legalization, and more.

Britain's third political party calls for marijuana legalization.
Marijuana Policy

Poll: Illinois Not Quite There Yet on Marijuana Legalization. A new Paul Simon Public Policy Institute poll has support for legalization at 45%, with 51% opposed. Medical marijuana does much better, with 82% in favor.

Massachusetts Senate Committee Issues Report on Dangers of Marijuana Legalization. A day after legalization got a raucous hearing at the state house, the Special Senate Committee on Marijuana issued a report saying it had "serious concerns about the prospect of legalizing marijuana for recreational use and sale" in the state. Legalization could make it easier for children to get access to the plant and more difficult for law enforcement trying to enforce impaired driving laws. The report calls for setting a legal driving limit for THC levels in the blood, requiring health risk warnings on marijuana products, and barring home cultivation, among other recommendations.

Medical Marijuana

Florida Senate Passes Medical Marijuana Expansion Bill. The Senate Monday approved House Bill 307, which would allow terminally ill patients to use medical marijuana. The bill now goes to the desk of Gov. Rick Scott (R).

Utah House Committee Kills Broad Medical Marijuana Bill, Tries to Merge It With Another One. The House Health and Human Services Committee effectively killed Senate Bill 73, backed by medical marijuana supporters, then tried to blend in some of its provisions into Senate Bill 89, which would allow doctors to recommend medical marijuana products, but would also impose stricter regulations on its use. Sen. Mark Madsen (R-Saratoga Springs), sponsor of SB 73, said the compromise wasn't good enough. "It's like trying to put live organs in a cadaver and expect some kind of good outcome. It is fundamentally, functionally constructed to fail," Madsen said. "It's entirely possible they wanted it to fail all along. I don't think it's going to come close to meeting any of the needs for the people. It was a placebo bill from the beginning and was intended to torpedo my bill." Medical marijuana activists will now most likely move forward with a threatened initiative.

Virginia Lawmakers Approve CBD Cannabis Oil Bill. The House Monday passed Senate Bill 701, which would allow the cultivation and use of two cannabinoids—CBD and THC-A—for patients suffering from severe epilepsy. The measure has already passed the Senate and now heads the desk of Gov. Terry McAuliffe (D).

Harm Reduction

Maryland Hearing Today on Groundbreaking Harm Reduction Bill Package. The House of Delegates is today holding hearings on two bills from Del. Dan Morhaim (D-Baltimore County) that are part of paradigm-shifting, four-bill harm reduction package. House Bill 1212 would allow for supervised consumption rooms, while House Bill 1267 would take initial steps toward enacting a pilot project in heroin and other opioid maintenance therapy.

International

British Liberal Democrats Call for Marijuana Legalization. In a report issued today, A Framework for a Regulated Cannabis Market in the UK, Britain's third largest political party called for legalizing marijuana and said it would be a billion dollar a year industry in the United Kingdom.  

Drug War Issues

Criminal JusticeAsset Forfeiture, Collateral Sanctions (College Aid, Drug Taxes, Housing, Welfare), Court Rulings, Drug Courts, Due Process, Felony Disenfranchisement, Incarceration, Policing (2011 Drug War Killings, 2012 Drug War Killings, 2013 Drug War Killings, 2014 Drug War Killings, 2015 Drug War Killings, 2016 Drug War Killings, Arrests, Eradication, Informants, Interdiction, Lowest Priority Policies, Police Corruption, Police Raids, Profiling, Search and Seizure, SWAT/Paramilitarization, Task Forces, Undercover Work), Probation or Parole, Prosecution, Reentry/Rehabilitation, Sentencing (Alternatives to Incarceration, Clemency and Pardon, Crack/Powder Cocaine Disparity, Death Penalty, Decriminalization, Defelonization, Drug Free Zones, Mandatory Minimums, Rockefeller Drug Laws, Sentencing Guidelines)CultureArt, Celebrities, Counter-Culture, Music, Poetry/Literature, Television, TheaterDrug UseParaphernalia, ViolenceIntersecting IssuesCollateral Sanctions (College Aid, Drug Taxes, Housing, Welfare), Violence, Border, Budgets/Taxes/Economics, Business, Civil Rights, Driving, Economics, Education (College Aid), Employment, Environment, Families, Free Speech, Gun Policy, Human Rights, Immigration, Militarization, Money Laundering, Pregnancy, Privacy (Search and Seizure, Drug Testing), Race, Religion, Science, Sports, Women's IssuesMarijuana PolicyGateway Theory, Hemp, Marijuana -- Personal Use, Marijuana Industry, Medical MarijuanaMedicineMedical Marijuana, Science of Drugs, Under-treatment of PainPublic HealthAddiction, Addiction Treatment (Science of Drugs), Drug Education, Drug Prevention, Drug-Related AIDS/HIV or Hepatitis C, Harm Reduction (Methadone & Other Opiate Maintenance, Needle Exchange, Overdose Prevention, Safe Injection Sites)Source and Transit CountriesAndean Drug War, Coca, Hashish, Mexican Drug War, Opium ProductionSpecific DrugsAlcohol, Ayahuasca, Cocaine (Crack Cocaine), Ecstasy, Heroin, Ibogaine, ketamine, Khat, Kratom, Marijuana (Gateway Theory, Marijuana -- Personal Use, Medical Marijuana, Hashish), Methamphetamine, New Synthetic Drugs (Synthetic Cannabinoids, Synthetic Stimulants), Nicotine, Prescription Opiates (Fentanyl, Oxycontin), Psychedelics (LSD, Mescaline, Peyote, Salvia Divinorum)YouthGrade School, Post-Secondary School, Raves, Secondary School